These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 14583650)
1. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine. Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650 [No Abstract] [Full Text] [Related]
2. International collaborative studies on potency assays of diphtheria and tetanus toxoids. Van Ramshorst JD; Sundaresan TK; Outschoorn AS Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488 [TBL] [Abstract][Full Text] [Related]
3. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids. Gupta RK; Siber GR Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950 [TBL] [Abstract][Full Text] [Related]
4. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria. Vrancheva S; Vulchev V; Bachev S Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199 [No Abstract] [Full Text] [Related]
5. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302 [TBL] [Abstract][Full Text] [Related]
6. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines. Csizér Z; Zsidai J Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225 [TBL] [Abstract][Full Text] [Related]
7. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines. Maheshwari SC; Sharma SB; Kumar A; Sokhey J J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418 [TBL] [Abstract][Full Text] [Related]
8. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines. Knight PA; Roberts PA Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931 [TBL] [Abstract][Full Text] [Related]
9. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method]. Unver SD; Ozcengiz E Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290 [TBL] [Abstract][Full Text] [Related]
10. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy. Brock B; Mckee B Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210 [No Abstract] [Full Text] [Related]
11. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine. Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366 [TBL] [Abstract][Full Text] [Related]
12. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
13. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines. Kreeftenberg JG Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932 [TBL] [Abstract][Full Text] [Related]
15. Experimental study on estimating the immunogenic potency of diphtheria and/or tetanus toxoids in monovaccines and associated vaccines. Durbacă S; Andronescu C; Diaconescu A Roum Arch Microbiol Immunol; 1996; 55(2):119-31. PubMed ID: 9253238 [TBL] [Abstract][Full Text] [Related]
16. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines. Maheshwari SC; Sharma SB; Ahuja S; Saxena SN J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614 [TBL] [Abstract][Full Text] [Related]
17. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules. Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838 [TBL] [Abstract][Full Text] [Related]
18. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay. Aggerbeck H; Heron I Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958 [TBL] [Abstract][Full Text] [Related]
19. Update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Mar; 50(10):189-90. PubMed ID: 11280456 [TBL] [Abstract][Full Text] [Related]
20. Quadruple vaccines containing pertussis and poliomyelitis vaccines. Anderson GR; Gottshall RY; Nelsom E; Angela F Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]